CN105481792A - Synthetic method with respect to pramipexole impurity C - Google Patents

Synthetic method with respect to pramipexole impurity C Download PDF

Info

Publication number
CN105481792A
CN105481792A CN201410498904.1A CN201410498904A CN105481792A CN 105481792 A CN105481792 A CN 105481792A CN 201410498904 A CN201410498904 A CN 201410498904A CN 105481792 A CN105481792 A CN 105481792A
Authority
CN
China
Prior art keywords
compound
add
synthetic method
benzothiazole
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201410498904.1A
Other languages
Chinese (zh)
Other versions
CN105481792B (en
Inventor
赵孝杰
刘远慧
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shandong Ailan Pharmaceutical Co.,Ltd.
Original Assignee
SHANDONG BOYUAN PHARMACEUTICAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHANDONG BOYUAN PHARMACEUTICAL CO Ltd filed Critical SHANDONG BOYUAN PHARMACEUTICAL CO Ltd
Priority to CN201410498904.1A priority Critical patent/CN105481792B/en
Publication of CN105481792A publication Critical patent/CN105481792A/en
Application granted granted Critical
Publication of CN105481792B publication Critical patent/CN105481792B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Thiazole And Isothizaole Compounds (AREA)

Abstract

The invention discloses a synthetic method with respect to a pramipexole impurity C and belongs to the field of drug synthesis. The method comprises the steps of: by taking a compound I 2-amino-6-propionyl amine-4,5,6,7-tetrahydrobenzothiazole as a raw material, generating a compound II 6-nitrogen[2-amino-4,6-tetrahydro1,3-benzothiazole-6-yl]-1-ethyl-2-methyl-3- carbonyl propyl hydrocarbyl]-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine under the action of sodium methylate, then performing a reaction on the compound II and dithioglycol to obtain a compound III 6-nitrogen[2-amino-4,6-tetrahydro1,3-benzothiazole-6-yl]-1-ethyl-2-methyl-3-ketone thioacetal propyl hydrocarbyl]-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine; and then by taking nickel as a catalyst, performing hydrogenation reduction to obtain a mixed isomer of a compound IV: (6S)-6-nitrogen[3-(6S)-2-amino-4,6-tetrahydro1,3-benzothiazole-6-yl]-1-ethyl-2-methyl propyl]-4,5,6,7-tetrahydro1,3-benzothiazole-2,6-diamine. The compound prepared by the method is relatively high in purity, and the method is simple to operate.

Description

A kind of synthetic method about pramipexole impurity C
Technical field
The present invention relates to the synthetic method of a kind of pramipexole impurity C.
Technical background
Pramipexole is used to the S&S for the treatment of idiopathic parkinsonism, and pramipexole is a kind of non-ergot class dopamine agonist.In vitro study shows, and the specificity of pramipexole to D2 acceptor is higher and have intrinsic activity completely, to the avidity of D3 acceptor higher than D2 and D4 acceptor.Pramipexole oral absorption is complete rapidly.
Mixed isomers (6S)-6-nitrogen [3-(6S)-2-amino-4,6-tetrahydrochysene 1,3-benzothiazol-6-yl)-1-Ethyl-2-Methyl propyl group]-4,5,6,7-tetrahydrochysene 1,3-benzothiazole-2,6-diamines is impurity contained in pramipexole finished product, does not also report its synthetic method in existing patent, document.
Summary of the invention
Introduction of the present invention be the synthetic method of a kind of impurity C of pramipexole
The synthetic route of pramipexole impurity C provided by the invention is as follows:
Compound I 2-amino-6-propionyl amine-4, 5, 6, 7-tetrahydro benzothiazol generates Compound II per 6-nitrogen [2-amino-4 under the effect of sodium methylate, 6-tetrahydrochysene 1, 3-benzothiazol-6-yl)-1-Ethyl-2-Methyl-3-carbonyl third alkyl]-4, 5, 6, 7-tetrahydrochysene-1, 3-benzothiazole-2, 6-diamines, Compound II per reacts to obtain compound III 6-nitrogen [2-amino-4 again with dithioglycol, 6-tetrahydrochysene 1, 3-benzothiazol-6-yl)-1-Ethyl-2-Methyl-3-contracting thioketones third alkyl]-4, 5, 6, 7-tetrahydrochysene-1, 3-benzothiazole-2, 6-diamines, compound III is that catalyst hydrogenation reduces and to obtain compound IV mixed isomers (6S)-6-nitrogen [3-(6S)-2-amino-4 with nickel, 6-tetrahydrochysene 1, 3-benzothiazol-6-yl)-1-Ethyl-2-Methyl propyl group]-4, 5, 6, 7-tetrahydrochysene 1, 3-benzothiazole-2, 6-diamines.
Preferably, alkaline reagents used in step a is the one in sodium methylate, sodium ethylate, sodium hydroxide or potassium hydroxide.
Preferably, solvent used in step a is the one in methyl alcohol, ethanol or Virahol.
Preferably, the range of reaction temperature in step b is 0-50 DEG C.
Preferably, in step c, used catalyst is nickel, Raney's nickel, or the one in palladium charcoal.
Preferably, the range of reaction temperature in step c is 0-50 DEG C.
Preferably, the mol ratio of Compound I and alkali is 1:1.0-1.4.
Preferably, the mol ratio of Compound I and dithioglycol is 1:1.0-1.1.
Preferred version is, comprises the following steps:
A, Compound I 2-amino-6-propionyl amine-4,5,6,7-tetrahydro benzothiazol add in reaction flask, then add methyl alcohol, add sodium methylate under stirring, are heated to backflow, are then cooled to room temperature.
B, slowly drip dithioglycol, dropwise rear temperature control stirring and react 3 hours, then concentrating under reduced pressure solvent evaporated, add wherein methylene dichloride stir molten clear after, add purified water agitator treating, point water-yielding stratum, in methylene dichloride, add magnesium sulfate stir dry, filtering siccative, evaporated under reduced pressure methylene dichloride.
C, add dehydrated alcohol wherein, stir molten clear after reaction solution is transferred to autoclave, add catalyzer, pressure 0.1mpa is kept with passing into hydrogen after nitrogen replacement, temperature control stirring reacts 3 hours, filtering reacting liquid, be evaporated to dry, add recrystallisation from isopropanol and obtain compound IV mixed isomers (6S)-6-nitrogen [amino-4, the 6-tetrahydrochysenes 1 of 3-(6S)-2-, 3-benzothiazol-6-yl)-1-Ethyl-2-Methyl propyl group]-4,5,6,7-tetrahydrochysene 1,3-benzothiazole-2,6-diamines.
Embodiment
In order to understand the present invention better, illustrate content of the present invention further below in conjunction with embodiment, but content of the present invention is not only confined to the following examples, embodiment should not regard as limiting the scope of the present invention.
Below in conjunction with example, the present invention will be further described:
Implement 1
Get 50g Compound I 2-amino-6-propionyl amine-4, 5, 6, 7-tetrahydro benzothiazol adds in 500ml there-necked flask, then methyl alcohol 200ml is added, 14.4g sodium methylate is added under stirring, be heated to back flow reaction 2 hours, then room temperature is cooled to, slow dropping 22g dithioglycol, dropwise rear temperature control 25 DEG C of stirring reactions 3 hours, then water-bath 40 DEG C of concentrating under reduced pressure solvent evaporated, add wherein 200ml methylene dichloride stir molten clear after, add purified water 200ml agitator treating, divide water-yielding stratum, 200ml purified water is added again in methylene dichloride, agitator treating, divide water-yielding stratum, in methylene dichloride, add 5g magnesium sulfate stir dry 1 hour, filtering siccative, temperature control less than 40 DEG C evaporated under reduced pressure methylene dichloride, add 200ml dehydrated alcohol wherein, stir molten clear after reaction solution is transferred to 500ml autoclave, add 65g nickel, pressure 0.1mpa is kept with passing into hydrogen after nitrogen replacement, temperature control 25 DEG C of stirring reactions 3 hours, filtering reacting liquid, be evaporated to dry, add 270ml recrystallisation from isopropanol and obtain compound IV mixed isomers (6S)-6-nitrogen [3-(6S)-2-amino-4, 6-tetrahydrochysene 1, 3-benzothiazol-6-yl)-1-Ethyl-2-Methyl propyl group]-4, 5, 6, 7-tetrahydrochysene 1, 3-benzothiazole-2, 6-diamines 29.0g, purity 98.2%, yield 61.0%.
Embodiment 2
Get 50g Compound I 2-amino-6-propionyl amine-4, 5, 6, 7-tetrahydro benzothiazol adds in 500ml there-necked flask, then ethanol 200ml is added, 18.2g sodium ethylate is added under stirring, be heated to back flow reaction 2 hours, then room temperature is cooled to, slow dropping 22g dithioglycol, dropwise rear temperature control 20 DEG C of stirring reactions 4 hours, then water-bath 40 DEG C of concentrating under reduced pressure solvent evaporated, add wherein 200ml methylene dichloride stir molten clear after, add purified water 200ml agitator treating, divide water-yielding stratum, 200ml purified water is added again in methylene dichloride, agitator treating, divide water-yielding stratum, in methylene dichloride, add 5g magnesium sulfate stir dry 1 hour, filtering siccative, temperature control 40 DEG C of evaporated under reduced pressure methylene dichloride, add 200ml dehydrated alcohol wherein, stir molten clear after reaction solution is transferred to 500ml autoclave, add 65g nickel, pressure 0.2mpa is kept with passing into hydrogen after nitrogen replacement, temperature control 30 DEG C of stirring reactions 2 hours, filtering reacting liquid, be evaporated to dry, add 270ml recrystallisation from isopropanol and obtain compound IV mixed isomers (6S)-6-nitrogen [3-(6S)-2-amino-4, 6-tetrahydrochysene 1, 3-benzothiazol-6-yl)-1-Ethyl-2-Methyl propyl group]-4, 5, 6, 7-tetrahydrochysene 1, 3-benzothiazole-2, 6-diamines 28.1g, purity 98.4%, yield 59.2%.
The above is the preferred embodiment of the present invention; for the practical study technician of the art; under the premise without departing from the principles of the invention, can also make some improvements and modifications, these improvements and modifications are also regarded as protection scope of the present invention.

Claims (9)

1. the present invention relates to a kind of synthetic method of pramipexole impurity C, it is characterized in that, comprise the following steps:
A), Compound I reacting by heating in alkaline environment obtains chemical combination II;
B), Compound II per and dithioglycol react to obtain compound III;
C), compound III obtains compound IV by hydro-reduction.
2., in synthetic method according to claim 1, alkaline reagents used in step a is sodium methylate, sodium ethylate, sodium hydroxide or potassium hydroxide.
3., in synthetic method according to claim 1, solvent used in step a is methyl alcohol, ethanol or Virahol.
4., in synthetic method according to claim 1, the range of reaction temperature in step b is 0-50 DEG C.
5., in synthetic method according to claim 1, in step c, used catalyst is nickel, Raney's nickel or palladium charcoal.
6., in synthetic method according to claim 1, the range of reaction temperature in step c is 0-50 DEG C.
7., in synthetic method according to claim 1, the mol ratio of Compound I and alkali is 1:1.0-1.4.
8., in synthetic method according to claim 1, the mol ratio of Compound I and dithioglycol is 1:1.0-1.1.
9., according to the synthetic method of the arbitrary described pramipexole impurity C of claim 1-8, it is characterized in that, comprise the following steps:
A, Compound I 2-amino-6-propionyl amine-4,5,6,7-tetrahydro benzothiazol add in reaction flask, then add methyl alcohol, add sodium methylate under stirring, are heated to backflow, are then cooled to room temperature;
B, slowly drip dithioglycol, dropwise rear temperature control stirring and react 3 hours, then concentrating under reduced pressure solvent evaporated, add wherein methylene dichloride stir molten clear after, add purified water agitator treating, point water-yielding stratum, in methylene dichloride, add magnesium sulfate stir dry, filtering siccative, evaporated under reduced pressure methylene dichloride;
C, add dehydrated alcohol wherein, stir molten clear after reaction solution is transferred to autoclave, add catalyzer, pressure 0.1mpa is kept with passing into hydrogen after nitrogen replacement, temperature control stirring reacts 3 hours, filtering reacting liquid, be evaporated to dry, add recrystallisation from isopropanol and obtain compound IV mixed isomers (6S)-6-nitrogen [amino-4, the 6-tetrahydrochysenes 1 of 3-(6S)-2-, 3-benzothiazol-6-yl)-1-Ethyl-2-Methyl propyl group]-4,5,6,7-tetrahydrochysene 1,3-benzothiazole-2,6-diamines.
CN201410498904.1A 2014-09-25 2014-09-25 A kind of Pramipexole impurity C synthetic method Active CN105481792B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410498904.1A CN105481792B (en) 2014-09-25 2014-09-25 A kind of Pramipexole impurity C synthetic method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410498904.1A CN105481792B (en) 2014-09-25 2014-09-25 A kind of Pramipexole impurity C synthetic method

Publications (2)

Publication Number Publication Date
CN105481792A true CN105481792A (en) 2016-04-13
CN105481792B CN105481792B (en) 2017-08-29

Family

ID=55669112

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410498904.1A Active CN105481792B (en) 2014-09-25 2014-09-25 A kind of Pramipexole impurity C synthetic method

Country Status (1)

Country Link
CN (1) CN105481792B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106749092A (en) * 2017-01-06 2017-05-31 成都倍特药业有限公司 A kind of synthetic method on Pramipexole impurity C
CN108084113A (en) * 2016-11-23 2018-05-29 江苏恒瑞医药股份有限公司 A kind of preparation method of Pramipexole impurity

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103012233A (en) * 2012-12-26 2013-04-03 华润赛科药业有限责任公司 Preparation method of N-(amino sulfo methyl)-5-oxo-1-propyl-2-pyrrolidine acetamide

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103012233A (en) * 2012-12-26 2013-04-03 华润赛科药业有限责任公司 Preparation method of N-(amino sulfo methyl)-5-oxo-1-propyl-2-pyrrolidine acetamide

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ALEXANDER H. SCHMIDT等: "In silico robustness testing of a compendial HPLC purity method by using of a multidimensional design space build by chromatography modeling-Case study pramipexole", 《JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS》 *
左延君: "亲水相互作用色谱质谱联用法测定盐酸普拉克索中有关物质", 《中国优秀硕士学位论文全文数据库 工程科技I辑》 *
陈佳: "盐酸普拉克索的合成与质量研究", 《中国优秀硕士学位论文全文数据库 工程科技I辑》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108084113A (en) * 2016-11-23 2018-05-29 江苏恒瑞医药股份有限公司 A kind of preparation method of Pramipexole impurity
CN108084113B (en) * 2016-11-23 2021-05-14 江苏恒瑞医药股份有限公司 Preparation method of pramipexole impurity
CN106749092A (en) * 2017-01-06 2017-05-31 成都倍特药业有限公司 A kind of synthetic method on Pramipexole impurity C
CN106749092B (en) * 2017-01-06 2019-06-04 成都倍特药业有限公司 A kind of synthetic method about Pramipexole impurity C

Also Published As

Publication number Publication date
CN105481792B (en) 2017-08-29

Similar Documents

Publication Publication Date Title
CN103910679B (en) The preparation method of the assorted Shandong of a kind of grace amine
CN104478670A (en) Preparation method of 5-bromine-2-chlorine-4'-ethyoxyl diphenylmethane
CN103304512A (en) Preparation method for febuxostat
CN103420891B (en) The synthetic method of type II diabetes medicine glimepiride intermediate benzene sulfanilamide (SN) triphosgene
CN101870682B (en) Preparation method of 4-methylthiazolaldehyde-5
CN108558628A (en) Benzoic preparation method
CN103086847B (en) Preparation method of phloroglucinol
CN102816122A (en) Preparation method of pyrimethanil
CN103880762B (en) A kind of preparation method of 1,2,3-triazole compound
CN105481792A (en) Synthetic method with respect to pramipexole impurity C
CN101665471B (en) Preparation method of febuxostat intermediate
CN113214133B (en) Synthesis method of melatonin
CN102372678A (en) Feed additive quinocetone and preparation method thereof
CN104072565A (en) High-yield simple preparation method of 17alpha-hydroxy progesterone
CN100537552C (en) Method for preparing Repaglinide
CN104311507A (en) Preparation method of (6S)-2,6-diamino-4,5,6,7-tetrahydrobenzothiazole
CN105218474B (en) The synthetic method of (4R, 5R) 2 dichloromethyl 4,5 dihydro 5 (4 methylsulfonyl phenyl) 4 oxazole methanol
CN103319416B (en) Novel veterinary drug triclabendazole sulfoxide and preparation method thereof
WO2020029720A1 (en) Method for preparing 2-chloro-6-methylthiotoluene
CN103319417A (en) Method for preparing triclabendazole sulfoxide
CN111116551B (en) 1-azaspiro [5.5] undecane-3-ones and 1-azaspiro [5.5] undecane-3-ols
CN104311469B (en) A kind of synthetic method of substituted indole-3-acetic acid
CN102702196B (en) Method for synthesizing 3-methyl-7-diazaindene
CN105198838A (en) Preparation method of repaglinide
CN105348285A (en) Low-cost and high-yield adenine preparation method

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20210113

Address after: 251200 east of zhaotu main canal, east of Chuangxin street, high tech Development Zone, Yucheng City, Dezhou City, Shandong Province

Patentee after: Shandong Ailan Pharmaceutical Co.,Ltd.

Address before: 251400 12 Taixing East Street, Jiyang County, Jinan City, Shandong Province

Patentee before: SHANDONG BOYUAN PHARMACEUTICAL Co.,Ltd.

TR01 Transfer of patent right